Partial door closure prevention spring

Information

  • Patent Grant
  • 11730892
  • Patent Number
    11,730,892
  • Date Filed
    Wednesday, December 21, 2016
    7 years ago
  • Date Issued
    Tuesday, August 22, 2023
    9 months ago
Abstract
A drug delivery device, including: housing, wherein said housing defines an opening and a chamber for a drug cartridge; a movable door connected to the housing, having a range of movement between a fully open position and a closed position, wherein the door blocks access to said opening when the door is in said closed position; a biasing element connected to the housing or the door, wherein the biasing element is positioned to interfere with the movement of the door by applying an opening force to open the door when the range of movement of the door is near the closed position, thus defining an exclusion zone; and a locking mechanism between the door and the housing, the locking mechanism applies a locking force on the door greater and in an opposite direction to the force applied by the biasing element.
Description
FIELD AND BACKGROUND OF THE INVENTION

The present invention, in some embodiments thereof, relates to a method for indicating the position of a door and, more particularly, but not exclusively, to a method for indicating the position of a medical device door.


SUMMARY OF THE INVENTION

Following are some examples of some embodiments of the invention:


Example 1. A drug delivery device, comprising: housing, wherein said housing defines an opening and a chamber for a drug cartridge;


a movable door connected to said housing, having a range of movement between a fully open position and a closed position, wherein said door blocks access to said opening when said door is in said closed position;


a biasing element connected to said housing or said door, wherein said biasing element is positioned to interfere with the movement of said door by applying an opening force to open said door when said range of movement of said door is near said closed position, thus defining an exclusion zone;


a locking mechanism between said door and said housing, said locking mechanism applies a locking force on said door greater and in an opposite direction to the force applied by said biasing element.


Example 2. The device of example 1, further comprising a drug dispensing mechanism; wherein closing of said movable door engages said drug dispensing mechanism to release drug from said drug cartridge.


Example 3. The device of examples 1 or 2, wherein said movable door is connected to said housing via a hinge, wherein said locking mechanism is positioned in a distance from said hinge at the contact point between said movable door and said housing.


Example 4. The device of any of the previous examples, wherein said movable door further comprising a hinge support, wherein when said movable door is closed said hinge support pushes said biasing element with a closing force which is greater than said opening force.


Example 5. The device of example 4, wherein when said opening force is greater than said closing force said biasing element moves said movable door to a perceptibly open position by pushing said hinge support.


Example 6. The device of example 4, wherein said movable door protrudes at least 4 mm from said housing when said movable door is in said perceptibly open position.


Example 7. The device of any of examples 3 to 6, wherein said biasing element applies said opening force when during the rotation of said movable door on said hinge said door reaches the last 20-30% of said range of movement.


Example 8. The device of any of examples 3 to 6, wherein said biasing element applies said opening force in the last 20-30 degrees of the rotation of said movable door on said hinge towards a closing position.


Example 9. The device of any one of examples 3 to 8, wherein said biasing element is positioned within said hinge.


Example 10. The device of any of the previous examples, wherein said door interlocks with locking geometries on said housing for locking said door.


Example 11. The device of any of the previous examples, wherein said locking mechanism irreversibly locks said movable door.


Example 12. The device of examples 1 or 2, wherein said door is a sliding door.


Example 13. The device of any of the previous examples, wherein said biasing element is a leaf spring, and/or a torsion spring.


Example 14. The device of any of the previous example, wherein said biasing element is a deformable element configured for elasticity deforming.


Example 15. The device of any of the previous examples, wherein said door further comprises a transmission to couple between a motor of said device and a drug cartridge when said door is in said closed position.


Example 16. A method for visually indicating that a door of a drug delivery device is open, comprising:


receiving by said door a closing force to move said door;


detecting that said door is not closed;


pushing said door with an opening force by a biasing element, to a perceptibly open position; and


indicating that said door is open by identifying said perceptibly open position of said door compared to said drug delivery device housing.


Example 17. The method of example 16, wherein said indicating further comprises indicating that said door is open by identifying at least one gap between said door and said drug delivery device housing.


Example 18. The method of examples 16 or 17, wherein said receiving further comprises receiving said closing force to move said door, wherein said closing force is greater than said opening force.


Example 19. The method of anyone of examples 16 to 18, wherein said detecting further comprises detecting that said door is not locked by a locking mechanism of said door and/or housing of said drug delivery device.


Example 20. The method of anyone of examples 16 to 19, wherein said indicating further comprises indicating that said door is open by visually identifying said perceptibly open position.


Example 21. The method of anyone of examples 16 to 19, wherein said indicating further comprises indicating that said door is open by touching said door and said drug delivery device housing.


Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.


Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings and images. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.


In the drawings:



FIGS. 1A-1C are schematic front views depicting different positions of a medical device door in relation to the medical device casing, according to some embodiments of the invention;



FIG. 2 is a graph showing the change in the force applied by a biasing element on a medical device door as a function of the door opening angle, according to some embodiments of the invention;



FIG. 3 is a flow chart depicting a process of closing a medical device door, according to some embodiments of the invention;



FIGS. 4A-4J are schematic views depicting the closing of a medical device rotating door, according to some embodiments of the invention;



FIGS. 5A-5G are schematic views depicting the closing of a medical device sliding door, according to some embodiments of the invention;



FIGS. 6A-6E are schematic views depicting different components of a medical device when the medical device door is in an open and a closed position, according to some embodiments of the invention; and



FIGS. 7A-7B are schematic views of an engagement mechanism between a motor of a medical device and a cartridge inserted into the medical device when the door of the medical device is open and when the door is closed, according to some embodiments of the invention.





DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION

The present invention, in some embodiments thereof, relates to a method for indicating the position of a door and, more particularly, but not exclusively, to a method for indicating the position of a medical device door.


An aspect of some embodiments relates to preventing a medical device door from being in an exclusion zone. In some embodiments, the exclusion zone is located near the closing position of the door. Alternatively, the exclusion zone is located at the last 50% of the medical device door range of movement, for example the last 5, 10, 15, 20%. In some embodiments, the exclusion zone is located at the last 25 degrees, for example last 20, 15, 10 degrees of the rotation of the device door towards a closed position.


In some embodiments, a biasing element applies a force on the door, when the door is within the exclusion zone. In some embodiments, the biasing element pushes the door open to a perceptibly open position. In some embodiments, when the door is at a perceptibly open position, a user of the device receives a clear visual indication that the door is open. Alternatively, when the door is at a perceptibly open position, a user can feel by touching the door and/or the device that the door is open. In some embodiments, for example, when the door is at a perceptibly open position the door protrudes at least 2 mm, for example 3, 4, 5, 6, 7 mm, from the device casing. In some embodiments, a potential advantage of having a biasing element which generates a limited range exclusion zone is that the biasing element does not interfere with access into the device when it pushes the door wide open. Additionally, having a device with a door wide open, for example when the door significantly protrudes out from the casing, may lead to problems during packaging and/or transportation of the device.


In some embodiments, a user applies force on the door in an opposite direction to the force applied by the biasing element, for example to move the door to a closing position. In some embodiments, the force applied by the user is larger than the opening force applied by the biasing element. In some embodiments, if the door is not further pushed by a user, then the biasing element pushes the door to the perceptibly open position.


In some embodiments, when the door is pushed to a closed position, a closing mechanism located on the door and/or on the medical device applies a greater force compared to the force applied by the biasing element. In some embodiments, the locking mechanism can be released, for example to allow opening of the door to a perceptibly open position by the biasing element. Alternatively, the locking element prevents the re-opening of the door, for example to ensure that the door remains closed, for example in case of a single use device.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.


In some embodiments, a drug dispensing mechanism of a drug delivery device, for example medical device 100 in FIGS. 1A-1C, operates to dispense drug molecules only when the medical device door, for example door 104 is closed on the device housing 102, for example as shown in FIG. 1A. Optionally, when the door is closed, the door is locked by a locking mechanism. In some embodiments, when the door is fully closed, a user of the device receives a visual indication that the door is closed. In some embodiments, when the door is closed there are no visible gaps between the door and the housing. Additionally, the door and the housing form a uniform outer surface of the medical device.


In some embodiments, if the door is not closed or is in a nearly closed position, for example as shown in FIG. 1B the drug is not dispensed. In some embodiments, when the door is in a nearly closed position, a user receives a visual indication that the door is closed because, for example a gap 105 formed between the door 104 and the housing 102 is not wide enough to indicate that the door is still open, and therefore the door is perceptibly closed. In some embodiments, when the door is a nearly closed position, a gap 107 formed between the door and an upper part 103 of the housing is not visible, and cannot be identified by touching the outer surface of the medical device 100. In some embodiments, when the door is still open but is perceptibly closed, a user activates the device but a drug cannot be delivered.


In some embodiments, in order to indicate to a user that the door is not closed, the door 104 is placed in a perceptibly open position. In some embodiments, in a perceptibly open position the gap formed between the door 104 and the housing 102, for example gap 105 is wide enough to visually indicate and/or to be identified by touch that the door is not closed. In some embodiments, the gap 107 formed between the door 104 and the upper part 103 of housing 102 is also visible and can be identified by touching the outer surface of the medical device, for example the upper part of the medical device 100 In some embodiments, when a user receives the indication that the door is not closed, he can then apply more force to close the door and optionally to ensure locking of the door.


Exemplary Formation of an Exclusion Zone


According to some embodiments, in order to place the door in a perceptibly open position, an exclusion zone is formed. In some embodiments, the door is not allowed to be positioned within the exclusion zone, unless a user applies force on the door.


Reference is now made to FIG. 2, describing the formation of an exclusion zone for a door position, according to some embodiments of the invention.


According to some exemplary embodiments, a biasing element for example an elastic biasing element or a deformable biasing element applies force on the door when the door is reaching a closed position. In some embodiments, the biasing element continuously applies force on the door from a near closed position until the door reaches a closing position. In some embodiments, an exclusion zone as long as the biasing element applies force on the door. In some embodiments, the biasing element applies enough force to move the door to perceptibly open position if the total force applied on the door is in the direction of the force applied by the biasing element.


According to some exemplary embodiments, when the door is pushed from an open position to a closing position of 0 degrees between the door and the device housing, a biasing element starts to apply force on the door when the door opening degree is less than 90 degrees. In some embodiments, the biasing element applies force on the door until the door reaches an angle of 0 degrees. Optionally, the biasing element applies force on the door when the door is closed or locked.


According to some exemplary embodiments, when the door opening angle degree is less than 90 degrees, a biasing element, for example a torsion spring gradually applies force on the door. In some embodiments, for example as seen in graph 204 a user needs to apply force larger than the force applied by the torsion spring and in an opposite direction until the door is closed. In some embodiments, the increase in force applied by the user against the torsion spring is more gradual compared to the force that needs to be applied against a leaf spring as seen in graph 202. In some embodiments, the amount of force that needs to be applied by a user to close the door depends on the elasticity of the biasing element.


In some embodiments, the leaf spring starts to apply force on the door when the door angle is less than 45 degrees. In some embodiments, the leaf spring and the torsion spring form an exclusion zone 206, however the exclusion zone formed by the torsion spring is larger compared to the exclusion zone formed by the leaf spring. In some embodiments, force application in wider opening angles, for example by the torsion spring allows to form larger exclusion zones. In some embodiments, a larger exclusion zone allows for example, a better indication that the door of the medical device is open.


According to some exemplary embodiments, when the door is closed or reaches a near closing position, a locking mechanism locks the door. In some embodiments, the locking mechanism applies a force larger than the biasing element. In some embodiments, when the door is locked the force applied by the user to keep the door closed is zero, as shown in graphs 202 and 204.


Exemplary Process for Closing a Door


According to some exemplary embodiments, a medical device user, closes a door of the device to allow the device to operate according to a desired activation process. Reference is now made to FIG. 3, depicting a process for closing a door of a medical device, according to some embodiments of the invention.


According to some exemplary embodiments, the door is closed by a user of the medical device at 302. In some embodiments, the user closes the door by applying sufficient force on the door to allow the door movement to a closing position. In some embodiments, the force applied by the user is larger than the force applied by a biasing element. Additionally, the force applied by the user is in and in an opposite direction to the force applied by the biasing element. In some embodiments, the user applies force on the door, to move the door to a locking position


According to some exemplary embodiments, the door movement is estimated at 304. In some embodiments, if the door moves less than 50% of the door range of movement, then the user visualizes the door position at 306, for example to receive a visual indication about the door position. In some embodiments, following the visualization of the door position, the user applies additional force to close the door at 312.


According to some exemplary embodiments, if the door moves more than 50% of the door range of movement, then the user checks whether the door is locked at 308. In some embodiments, if the door is locked, then no further actions are requires. Alternatively, if the door is not locked then a biasing element pushes the door open at 310. In some embodiments, the biasing element pushes the door to a perceptibly open position.


According to some exemplary embodiments, the user visualizes the door position at 306. In some embodiments, the user visualizes that the door is at a perceptibly open position at 306, optionally by visualizing a gap between the door and the device casing, for example gap 108 shown in FIG. 1C.


According to some exemplary embodiments, if the door is visualized in a perceptibly open position, then the user applies additional force to close the door at 312. In some embodiments, the user applies a larger force on the door at 312. In some embodiments, after the additional force is applied by the user, the door movement is estimated at 304, as previously described.


Exemplary Closing of a Rotating Door


Reference is now made to FIGS. 4A-4J depicting the closing of a rotating medical device door, according to some embodiments of the invention.


According to some exemplary embodiments, medical device 400 comprises a movable door, for example rotating door 404 and housing 402, and a biasing element 406 connected to housing 402. In some embodiments, the rotating door 404 is connected to housing 402 via a hinge 405 which allows the axial rotation of the rotating door 404. In some embodiments a hinge support 403 is connected to rotating door 404. In some embodiments, the biasing element is positioned on the left side of the hinge support. Alternatively, for example when the hinge is placed on the right side of the biasing element, the hinge support is positioned on the left side of the biasing element.


According to some exemplary embodiments, for example as shown in FIG. 4A, when the rotating door 404 is in an open position, biasing element 406 is not in contact with the door or with hinge support 403, and therefore does not apply force on the door.


According to some exemplary embodiments, for example as shown in FIG. 4B, biasing element 406 is in contact with the hinge support 403, and optionally applies minimal or zero force on hinge support 403. In some embodiments, in this position, the rotating door 404 is placed in a perceptibly open position, for example a position that allows a visual indication that the door is open. In some embodiments, the biasing element 406 makes contact with the rotating door 404 or with the hinge support 403 at the last 45 degrees 414, for example last 30, 25, 20, 15, 10 degrees of the door rotation towards closing position.


According to some exemplary embodiments, for example as shown in FIG. 4C, to close the rotating door, an additional force is applied in direction 410, in an opposite direction to the force applied by the biasing element 406 on the hinge support 403. In some embodiments, if the force applied in direction 410 is zero, or is smaller than the force applied by the biasing element 406, then the rotating door 404 is pushed open, for example to the perceptibly open position shown in FIG. 4B. Alternatively, if the force applied in direction 410 is larger than the force applied by the biasing element and is applied for a sufficient time period, the rotating door 404 is closed, for example as shown in FIG. 4D. In some embodiments, when the door is closed the hinge support pushes the biasing element into a groove within housing 402. Optionally, when the door is closed a locking mechanism locks the door. In some embodiments, the locking mechanism irreversibly locks the door.


Reference is now made to FIGS. 4E-4G, depicting closing a rotating door by application of force against a biasing element in the form of a leaf spring, according to some embodiments of the invention.


According to some exemplary embodiments, for example as shown in FIG. 4E, a biasing element in the form of a leaf spring 420 is connected to housing 422. In some embodiments, when the door, for example door 424 is in perceptibly open position, leaf spring 420 is in contact with a hinge support 426 of door 424. In a perceptibly open position, the leaf spring 420 prevents the closure of door 424 unless an additional force is applied by moving the door 424 in direction 410. In some embodiments, when the door is moved in direction 410 until it reaches a closed position, the hinge support 426 applies sufficient force to bend leaf spring 420, for example as shown in FIG. 4G.


Reference is now made to FIGS. 4H-4J, depicting closing a rotating door by application of force against a biasing element in the form of a torsion spring, according to some embodiments of the invention.


According to some exemplary embodiments, for example as shown in FIG. 4H, a biasing element in the form of a torsion spring 430 is connected to housing 432. In some embodiments, when the door, for example door 434 is in perceptibly open position, torsion spring 430 is in contact with door 434. In a perceptibly open position, the torsion spring 430 prevents the closure of door 434 unless an additional force is applied by moving the door 434 in direction 410. In some embodiments, when the door is moved in direction 410 until it reaches a closed position, the door 434 applies sufficient force to bend torsion spring 430, for example as shown in FIG. 4J.


Exemplary Closing of a Sliding Door


Reference is now made to FIGS. 5A-5D depicting the closing of a sliding medical device door, according to some embodiments of the invention.


According to some exemplary embodiments, medical device 500 comprises a sliding door 502, housing 504 and a biasing element 506 connected to housing 504. In some embodiments, for example as shown in FIG. 5A, the sliding door 502 is open and is not in contact with the biasing element 506. In some embodiments, in this position device components are inserted into the housing 504, for example a drug cartridge.


According to some exemplary embodiments, for example as shown in FIG. 5B a user applies force on the sliding door 502 in direction 508 to push the door to a closing position. In some embodiments, when the biasing element 506 applies minimal force or zero force on the sliding door 502, sliding door is positioned in a perceptibly open position.


According to some exemplary embodiments, in order to further push and close the sliding door 502, the user applies force in direction 508 in an opposite direction to the force applied by the biasing element, for example as shown in FIG. 5C. In some embodiments, the force applied by the user is larger than the force applied by the biasing element. Optionally, the user applies the force until the door is closed. In some embodiments, if the user stops applying the force before the sliding door 502 is closed, then the biasing element pushes the door in direction 510 to the perceptibly open position shown in FIG. 5B.


According to some exemplary embodiments, if the sliding door 502 is pushed by the user for a sufficient time period with a force larger than the force applied by biasing element, then the door is closed, for example as shown in FIG. 5D. In some embodiments, when the sliding door 502 is closed a locking mechanism placed on the door and/or on the housing 504 locks the door. In some embodiments, the locking mechanism applies force which is larger than the force applied by the biasing element, for example to prevent the opening of the door.


Reference is now made to FIGS. 5E-5G depicting a medical device with a sliding door in an open and a closed position, according to some embodiments of the invention.


According to some exemplary embodiments, when sliding door 522 of medical device 520 is in an open position, for example as shown in FIG. 5E, drug cartridge 524 is pushed in direction 526 into housing 528. In some embodiments, when the drug cartridge 524 is placed inside housing 528, the sliding door 522 is pushed in direction 530, for example to cover the drug cartridge 524. In some embodiments, to completely cover the drug cartridge sliding door 522 applies force against a biasing element connected to housing 528. In some embodiments, when the sliding door 522 is in a fully closed position, and is optionally locked, the drug cartridge 524 is fully covered, for example as shown in FIG. 5G. Optionally, when the sliding door 522 is locked, a drug can be delivered when medical device 520 is activated.


Exemplary Drug Delivery Device


Reference is now made to FIGS. 6A-6E depicting a drug delivery device, according to some embodiments of the invention.


According to some exemplary embodiments, a drug delivery device 600 comprising housing 602 and a movable door, for example rotating door 604 connected to housing 602 via hinge 606. In some embodiments, housing 602 defines a chamber for a drug reservoir, for example cartridge 614. In some embodiments, cartridge 614 stores drug molecules that are released when a drug dispensing mechanism of device 600 is engaged.


According to some exemplary embodiments, drug delivery device 600 further comprising a biasing element, for example a leaf spring 610 and/or torsion spring 612, connected to housing 602. In some embodiments, door 604 is connected to hinge 606 via hinge support 608. In some embodiments, when the door 604 is in a fully open position, for example as shown in FIG. 6A, the door is not in contact with the biasing element, and does not apply any force on the biasing element. In some embodiments, when the door 604 is pushed in direction 620 to a perceptibly open position, for example as shown in FIGS. 6B and 6D, the biasing element, for example leaf spring 610 or torsion spring 612 is in contact with the door 604. Alternatively, the biasing element is in contact with the hinge support 608. In some embodiments, when the door 604 is in a perceptibly open position, the biasing element prevents the closure of the door unless sufficient force is applied in direction 620.


According to some exemplary embodiments, when the door 604 moves in direction 620, the door applies additional force on the biasing element. Alternatively, when the door 604 moves in direction 620, the hinge support 608 applies additional force on the biasing element, for example on the leaf spring 610. Optionally, when the door moves in direction 620 an increasing force is applied on the biasing element.


According to some exemplary embodiments, door 604 is further pushed in direction 620 with a force greater than the force applied by the biasing element in order to reach a closing position. In some embodiments, when door 604 is closed, for example as shown in FIGS. 6C and 6E, a locking mechanism placed at the distal end of the door, for example locking mechanism 616 locks door 604 to housing 602. Alternatively or additionally, locking mechanism 618 placed on housing 602 locks door 602 and/or locking mechanism 616. In some embodiments, locking mechanism is placed in the contact point between door 604 and housing 602. Optionally, the locking mechanism is placed in a distance from hinge 606. In some embodiments, the door interlocks with locking geometries on said housing.


According to some exemplary embodiments, if door 604 is not locked and there is no force applied in direction 620, the biasing element, for example leaf spring 610 or torsion spring 612 pushes the door back to the perceptibly open position, for example the perceptibly open position shown in FIGS. 6B and 6D.


According to some exemplary embodiments, both a torsion spring and a leaf spring are connected to the housing of a medical device and apply force on the door. In some embodiments, the torsion spring applies force on the door at least at the last 50% of the door range of movement towards closure. In some embodiments, the leaf spring applies additional force on the door at least at the last 30% of the door range of movement towards closure.


According to some exemplary embodiments, when door 604 remains closed or locked, a drug dispensing mechanism of the drug delivery device is engaged, for example to allow drug dispensing from cartridge 614 upon device activation. In some embodiments, when door 604 is partially open, for example when door 604 is in a perceptibly open position, drug dispensing mechanism is not engaged and drug is not released from cartridge 614 when the device is activated.


According to some exemplary embodiments, the biasing element is an elastic element made from metal. Alternatively, the biasing element is a deformable element with a limited elastic range and is made, for example from plastic or elastomer.


Exemplary Engaging Drug Dispensing Mechanism


Reference is now made to FIGS. 7A and 7B, depicting the engagement of a drug dispensing mechanism, according to some embodiments of the invention.


According to some exemplary embodiments, medical device 650 comprising a motor mechanism 710 and a cartridge mechanism 712 of drug cartridge 614. In some embodiments, when door 604 is not closed for example when door is in a perceptibly open position the cartridge mechanism 712 is not engaged to motor mechanism 710. In some embodiments, when cartridge mechanism 712 is not engaged, a drug cannot be dispensed from cartridge 614, optionally even if the medical device 650 is activated by a user.


According to some exemplary embodiments, when door 604 is closed, for example by applying additional force against the biasing element 612, the cartridge mechanism 712 is engaged to motor mechanism 710. In some embodiments, a door transmission 714 is connected to door 604 and is coupled between the motor mechanism 710 and the cartridge mechanism 712, for example as shown in FIG. 7B. In some embodiments, when door 604 is closed, the door transmission 714 delivers the rotation of the motor mechanism 710 to the cartridge mechanism 712, for example to dispense drug from cartridge 614 upon medical device 650 activation.


It is expected that during the life of a patent maturing from this application many relevant biasing elements will be developed; the scope of the term biasing element is intended to include all such new technologies a priori.


As used herein with reference to quantity or value, the term “about” means “within ±10% of”.


The terms “comprises”, “comprising”, “includes”, “including”, “has”, “having” and their conjugates mean “including but not limited to”.


The term “consisting of” means “including and limited to”.


The term “consisting essentially of” means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.


As used herein, the singular forms “a”, “an” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a compound” or “at least one compound” may include a plurality of compounds, including mixtures thereof.


Throughout this application, embodiments of this invention may be presented with reference to a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as “from 1 to 6” should be considered to have specifically disclosed subranges such as “from 1 to 3”, “from 1 to 4”, “from 1 to 5”, “from 2 to 4”, “from 2 to 6”, “from 3 to 6”, etc.; as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.


Whenever a numerical range is indicated herein (for example “10-15”, “10 to 15”, or any pair of numbers linked by these another such range indication), it is meant to include any number (fractional or integral) within the indicated range limits, including the range limits, unless the context clearly dictates otherwise. The phrases “range/ranging/ranges between” a first indicate number and a second indicate number and “range/ranging/ranges from” a first indicate number “to”, “up to”, “until” or “through” (or another such range-indicating term) a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numbers therebetween.


Unless otherwise indicated, numbers used herein and any number ranges based thereon are approximations within the accuracy of reasonable measurement and rounding errors as understood by persons skilled in the art.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.

Claims
  • 1. A drug delivery device, comprising: a housing defining an opening and a chamber configured to receive a drug cartridge;a motor within the housing;a door connected to the housing, the door having a range of movement between a fully open position and a closed position, wherein the door blocks access to the opening when the door is in the closed position;a transmission that is configured to couple the motor and the drug cartridge when the door is in the closed position and decouple the motor and the drug cartridge when the door is in the open position;a biasing element connected to the housing or the door, wherein the biasing element is positioned to interfere with the movement of the door by applying an opening force to open the door when the door reaches a last 30 degrees of a rotation of the door toward the closed position or when the door reaches a last 30% of the range of movement during the rotation of the door toward the closed position; anda locking mechanism between the door and the housing, the locking mechanism applying a locking force on the door greater and in an opposite direction to the opening force applied by the biasing element.
  • 2. The drug delivery device of claim 1, further comprising a drug dispensing mechanism, wherein closing of the door engages the drug dispensing mechanism to release drug from the drug cartridge.
  • 3. The drug delivery device of claim 1, wherein the door is connected to the housing via a hinge, and wherein the locking mechanism is at a contact point that is between the door and the housing and that is spaced from the hinge.
  • 4. The drug delivery device of claim 1, wherein the door further comprises a hinge support, and wherein when the door is in the closed position, the hinge support pushes the biasing element with a closing force which is greater than the opening force.
  • 5. The drug delivery device of claim 4, wherein when the opening force is greater than the closing force, the biasing element moves the door to an intermediate position by pushing the hinge support, the intermediate position being between the closed position and the fully open position.
  • 6. The drug delivery device of claim 5, wherein the door protrudes at least 4 mm from the housing when the door is in the intermediate position.
  • 7. The drug delivery device of claim 3, wherein the biasing element is positioned within the hinge.
  • 8. The drug delivery device of claim 1, wherein the door interlocks with the housing for locking the door.
  • 9. The drug delivery device of claim 1, wherein the locking mechanism irreversibly locks the door.
  • 10. The drug delivery device of claim 1, wherein the door is a sliding door.
  • 11. The drug delivery device of claim 1, wherein the biasing element is a leaf spring or a torsion spring.
  • 12. The drug delivery device of claim 1, wherein the biasing element is configured to elasticity deform.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a section 371 of International Application No. PCT/US16/068049, filed Dec. 21, 2016, which was published Feb. 8, 2018 under International Publication No. WO 2018/026385 A1, which claims the benefit of U.S. Provisional Application No. 62/369,505, filed Aug. 1, 2016, the contents of which are incorporated herein by their entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2016/068049 12/21/2016 WO
Publishing Document Publishing Date Country Kind
WO2018/026385 2/8/2018 WO A
US Referenced Citations (747)
Number Name Date Kind
1795630 Wilson Mar 1931 A
2860635 Wilburn Nov 1958 A
3203269 Perrine Aug 1965 A
3212685 James et al. Oct 1965 A
3782365 Pinna Jan 1974 A
3794028 Mueller et al. Feb 1974 A
3946732 Hurscham Mar 1976 A
3994295 Wulff Nov 1976 A
4026128 Blanco May 1977 A
4167663 Granzow et al. Sep 1979 A
4195636 Behnke Apr 1980 A
4218724 Kaufman Aug 1980 A
4273122 Whitney et al. Jun 1981 A
4276879 Yiournas Jul 1981 A
4300554 Hessberg et al. Nov 1981 A
4396385 Kelly et al. Aug 1983 A
4403987 Gottinger Sep 1983 A
4435173 Siposs et al. Mar 1984 A
4465478 Sabelman et al. Aug 1984 A
4565543 Bekkering et al. Jan 1986 A
4585439 Michel Apr 1986 A
4599082 Grimard Jul 1986 A
4601702 Hudson Jul 1986 A
4634426 Kamen Jan 1987 A
4685903 Cable et al. Aug 1987 A
4689043 Bisha Aug 1987 A
4698055 Sealfon Oct 1987 A
4810215 Kaneko Mar 1989 A
4850966 Grau et al. Jul 1989 A
4867743 Vaillancourt Sep 1989 A
4886499 Cirelli et al. Dec 1989 A
4908014 Kroyer Mar 1990 A
4919596 Slate et al. Apr 1990 A
4929241 Kulli May 1990 A
4950235 Slate et al. Aug 1990 A
4950246 Muller Aug 1990 A
D322671 Szwarc Dec 1991 S
5090877 D'Silva Feb 1992 A
5109850 Blanco et al. May 1992 A
5112317 Michel May 1992 A
5131816 Brown et al. Jul 1992 A
5190521 Hubbard et al. Mar 1993 A
5254096 Rondelet et al. Oct 1993 A
5300045 Plassche, Jr. Apr 1994 A
5342313 Campbell et al. Aug 1994 A
5348544 Sweeney et al. Sep 1994 A
5354287 Wacks Oct 1994 A
5364364 Kasvikis et al. Nov 1994 A
5366498 Brannan et al. Nov 1994 A
5383865 Michel Jan 1995 A
5411482 Campbell May 1995 A
5445621 Poli et al. Aug 1995 A
5478315 Brothers et al. Dec 1995 A
5482446 Williamson et al. Jan 1996 A
5496274 Graves et al. Mar 1996 A
5501665 Jhuboo et al. Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
D372098 Lattin et al. Jul 1996 S
5558639 Gangemi et al. Sep 1996 A
5562686 Sauer et al. Oct 1996 A
5593390 Castellano et al. Jan 1997 A
5616132 Newman Apr 1997 A
5643218 Lynn et al. Jul 1997 A
5645955 Maglica Jul 1997 A
5647853 Feldmann et al. Jul 1997 A
5658133 Anderson et al. Aug 1997 A
5662678 Macklin Sep 1997 A
5672160 Oesterlind et al. Sep 1997 A
D384745 Lattin et al. Oct 1997 S
5690618 Smith et al. Nov 1997 A
D393314 Meisner et al. Apr 1998 S
5766186 Faraz et al. Jun 1998 A
5779676 Kriesel et al. Jul 1998 A
5795675 Maglica Aug 1998 A
5800420 Gross et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5814020 Gross Sep 1998 A
5820406 Hetherington Oct 1998 A
5830187 Kriesel et al. Nov 1998 A
5836920 Robertson Nov 1998 A
5848991 Gross et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5858008 Capaccio Jan 1999 A
5868710 Battiato et al. Feb 1999 A
5931814 Alex et al. Aug 1999 A
5941850 Shah et al. Aug 1999 A
5948392 Haslwanter et al. Sep 1999 A
5954697 Srisathapat et al. Sep 1999 A
5957895 Sage et al. Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5993423 Choi Nov 1999 A
5997501 Gross et al. Dec 1999 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6033245 Yamkovoy Mar 2000 A
6033377 Rasmussen et al. Mar 2000 A
6064797 Crittendon et al. May 2000 A
6074369 Sage et al. Jun 2000 A
6117575 Dinsdale Sep 2000 A
6138865 Gilmore Oct 2000 A
6149614 Dunshee et al. Nov 2000 A
6160487 DeLuca Dec 2000 A
6175688 Cassidy et al. Jan 2001 B1
6186982 Gross et al. Feb 2001 B1
6200289 Hochman et al. Mar 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6224569 Brimhall May 2001 B1
6248093 Moberg Jun 2001 B1
6277095 Kriesel et al. Aug 2001 B1
6277098 Klitmose et al. Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6287283 Ljunggreen et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302633 Poe Oct 2001 B1
6305908 Hermann et al. Oct 2001 B1
6336729 Pavelle et al. Jan 2002 B1
6345968 Shupe Feb 2002 B1
6362591 Moberg Mar 2002 B1
6377848 Garde et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6423029 Elsberry Jul 2002 B1
6423035 Das et al. Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
D465026 May et al. Oct 2002 S
6458102 Mann et al. Oct 2002 B1
6485461 Mason et al. Nov 2002 B1
6485465 Moberg et al. Nov 2002 B2
6500150 Gross et al. Dec 2002 B1
6503231 Prausnitz et al. Jan 2003 B1
6511336 Turek et al. Jan 2003 B1
6517517 Farrugia et al. Feb 2003 B1
D471274 Diaz et al. Mar 2003 S
D471983 Hippolyte et al. Mar 2003 S
6530901 Tsukada et al. Mar 2003 B1
6555986 Moberg Apr 2003 B2
6558351 Steil et al. May 2003 B1
6589229 Connelly et al. Jul 2003 B1
6595205 Andersson Jul 2003 B2
6595956 Gross et al. Jul 2003 B1
6595960 West et al. Jul 2003 B2
6599272 Hjerlman et al. Jul 2003 B1
6632201 Mathias et al. Oct 2003 B1
6645181 Lavi et al. Nov 2003 B1
6652482 Hochman Nov 2003 B2
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6659980 Moberg et al. Dec 2003 B2
6673033 Sciulli et al. Jan 2004 B1
6679862 Diaz et al. Jan 2004 B2
6689118 Alchas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6752787 Causey et al. Jun 2004 B1
6768425 Flaherty et al. Jul 2004 B2
6786890 Preuthun et al. Sep 2004 B2
6800071 Mcconnell et al. Oct 2004 B1
6805687 Dextradeur et al. Oct 2004 B2
6824529 Gross et al. Nov 2004 B2
6843782 Gross et al. Jan 2005 B2
6854620 Ramey Feb 2005 B2
6905298 Haring Jun 2005 B1
6908452 Diaz et al. Jun 2005 B2
6950028 Zweig Sep 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6972002 Thorne Dec 2005 B2
6997727 Legrady et al. Feb 2006 B1
7001360 Veasey et al. Feb 2006 B2
7034223 Fan et al. Apr 2006 B2
7048715 Diaz et al. May 2006 B2
7060054 Nissels Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7097637 Triplett et al. Aug 2006 B2
7128727 Flaherty et al. Oct 2006 B2
7144384 Gorman et al. Dec 2006 B2
7193521 Moberg et al. Mar 2007 B2
D544092 Lewis Jun 2007 S
7225694 Said Jun 2007 B2
7247149 Beyerlein Jul 2007 B2
7250037 Shermer et al. Jul 2007 B2
7267669 Staunton et al. Sep 2007 B2
7291132 Deruntz et al. Nov 2007 B2
7291159 Schmelzeisen-Redeker et al. Nov 2007 B2
7303549 Flaherty et al. Dec 2007 B2
7344385 Chen Mar 2008 B2
7364570 Gerondale et al. Apr 2008 B2
7390314 Stutz et al. Jun 2008 B2
7407493 Cane Aug 2008 B2
D578210 Muta et al. Oct 2008 S
7455663 Bikovsky Nov 2008 B2
7465290 Reilly Dec 2008 B2
7488181 Van Feb 2009 B2
7497842 Diaz et al. Mar 2009 B2
7501587 English Mar 2009 B2
7503786 Kato et al. Mar 2009 B2
7524304 Genosar Apr 2009 B2
7530964 Lavi et al. May 2009 B2
7547281 Hayes et al. Jun 2009 B2
7563253 Tanner et al. Jul 2009 B2
7565208 Harris et al. Jul 2009 B2
7569050 Moberg et al. Aug 2009 B2
D600341 Loerwald Sep 2009 S
7585287 Bresina et al. Sep 2009 B2
7588559 Aravena et al. Sep 2009 B2
7589974 Grady et al. Sep 2009 B2
D602155 Foley et al. Oct 2009 S
D602586 Foley et al. Oct 2009 S
D604835 Conley Nov 2009 S
7621893 Moberg et al. Nov 2009 B2
7628770 Ethelfeld Dec 2009 B2
7628772 Mcconnell et al. Dec 2009 B2
7628782 Mair et al. Dec 2009 B2
7637891 Wall Dec 2009 B2
7637899 Woolston et al. Dec 2009 B2
7641649 Moberg et al. Jan 2010 B2
7660627 Mcnichols et al. Feb 2010 B2
7678079 Shermer et al. Mar 2010 B2
7682338 Griffin Mar 2010 B2
7686787 Moberg et al. Mar 2010 B2
7699829 Harris et al. Apr 2010 B2
7699833 Moberg et al. Apr 2010 B2
7704088 Sakamoto Apr 2010 B2
7704227 Moberg et al. Apr 2010 B2
7704229 Moberg et al. Apr 2010 B2
7704231 Pongpairochana et al. Apr 2010 B2
7708717 Estes et al. May 2010 B2
7713238 Mernoe May 2010 B2
7713240 Istoc et al. May 2010 B2
7717913 Novak et al. May 2010 B2
7722574 Toman et al. May 2010 B2
7736344 Moberg et al. Jun 2010 B2
7744589 Mounce et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7753879 Mernoe Jul 2010 B2
7766873 Moberg et al. Aug 2010 B2
7776030 Estes et al. Aug 2010 B2
7780636 Radmer et al. Aug 2010 B2
7780637 Jerde et al. Aug 2010 B2
7789857 Moberg et al. Sep 2010 B2
7789862 Thorne, Jr. Sep 2010 B2
7801599 Young et al. Sep 2010 B2
7806868 De Polo et al. Oct 2010 B2
7815622 Istoc et al. Oct 2010 B2
7828528 Estes et al. Nov 2010 B2
7837659 Bush et al. Nov 2010 B2
7846132 Gravesen et al. Dec 2010 B2
7854723 Hwang et al. Dec 2010 B2
7857131 Vedrine Dec 2010 B2
7879025 Jacobson et al. Feb 2011 B2
7879026 Estes et al. Feb 2011 B2
7892206 Moberg et al. Feb 2011 B2
7918825 O'Connor et al. Apr 2011 B2
7918843 Genosar et al. Apr 2011 B2
7935104 Yodat et al. May 2011 B2
7935105 Miller et al. May 2011 B2
7938803 Mernoe et al. May 2011 B2
7955305 Moberg et al. Jun 2011 B2
7967784 Pongpairochana et al. Jun 2011 B2
7967795 Cabiri Jun 2011 B1
7981105 Adair et al. Jul 2011 B2
7988683 Adair et al. Aug 2011 B2
7993300 Nyholm et al. Aug 2011 B2
7993301 Boyd et al. Aug 2011 B2
7998111 Moberg et al. Aug 2011 B2
8021357 Tanaka et al. Sep 2011 B2
8025658 Chong et al. Sep 2011 B2
8029469 Ethelfeld Oct 2011 B2
8034019 Nair et al. Oct 2011 B2
8038666 Triplett et al. Oct 2011 B2
8057431 Woehr et al. Nov 2011 B2
8057436 Causey et al. Nov 2011 B2
8062253 Nielsen et al. Nov 2011 B2
8062257 Moberg et al. Nov 2011 B2
8065096 Moberg et al. Nov 2011 B2
8066694 Wagener Nov 2011 B2
D650079 Presta et al. Dec 2011 S
D650903 Kosinski et al. Dec 2011 S
8086306 Katzman et al. Dec 2011 B2
D652503 Cameron et al. Jan 2012 S
8105279 Mernoe et al. Jan 2012 B2
8114046 Covino et al. Feb 2012 B2
8114064 Alferness et al. Feb 2012 B2
8114066 Naef et al. Feb 2012 B2
D657462 Siroky Apr 2012 S
8147446 Yodat et al. Apr 2012 B2
8152764 Istoc et al. Apr 2012 B2
8152770 Reid Apr 2012 B2
8152779 Cabiri Apr 2012 B2
8152793 Keinaenen et al. Apr 2012 B2
8157693 Waksmundzki Apr 2012 B2
8157769 Cabiri Apr 2012 B2
8162674 Cho et al. Apr 2012 B2
8162923 Adams et al. Apr 2012 B2
8167841 Teisen-Simony et al. May 2012 B2
8172591 Wertz May 2012 B2
8172804 Bikovsky May 2012 B2
8182447 Moberg et al. May 2012 B2
8182462 Istoc et al. May 2012 B2
8197444 Bazargan et al. Jun 2012 B1
8206351 Sugimoto et al. Jun 2012 B2
8221356 Enggaard et al. Jul 2012 B2
8267893 Moberg et al. Sep 2012 B2
8267921 Yodat et al. Sep 2012 B2
8287520 Drew et al. Oct 2012 B2
8292647 Mcgrath et al. Oct 2012 B1
8308679 Hanson et al. Nov 2012 B2
8323250 Chong et al. Dec 2012 B2
8348898 Cabiri Jan 2013 B2
8372039 Mernoe et al. Feb 2013 B2
8373421 Lindegger et al. Feb 2013 B2
8409142 Causey et al. Apr 2013 B2
8414557 Istoc et al. Apr 2013 B2
8430847 Mernoe et al. Apr 2013 B2
D685083 Schneider et al. Jun 2013 S
8465455 Cabiri Jun 2013 B2
8469942 Kow et al. Jun 2013 B2
D687141 Schneider et al. Jul 2013 S
8474332 Bente et al. Jul 2013 B2
8475408 Mernoe et al. Jul 2013 B2
8479595 Vazquez et al. Jul 2013 B2
8483980 Moberg et al. Jul 2013 B2
8495918 Bazargan et al. Jul 2013 B2
8496862 Zelkovich et al. Jul 2013 B2
D687536 Guarraia et al. Aug 2013 S
8512287 Cindrich et al. Aug 2013 B2
8517987 Istoc et al. Aug 2013 B2
8523803 Favreau Sep 2013 B1
D692552 Lovell et al. Oct 2013 S
8556856 Bazargan et al. Oct 2013 B2
8562364 Lin et al. Oct 2013 B2
8574216 Istoc et al. Nov 2013 B2
8603026 Favreau Dec 2013 B2
8603027 Favreau Dec 2013 B2
8617110 Moberg et al. Dec 2013 B2
8628510 Bazargan et al. Jan 2014 B2
8647074 Moberg et al. Feb 2014 B2
8647296 Moberg et al. Feb 2014 B2
8668672 Moberg et al. Mar 2014 B2
8674288 Hanson et al. Mar 2014 B2
8679060 Mernoe et al. Mar 2014 B2
8681010 Moberg et al. Mar 2014 B2
8690855 Alderete et al. Apr 2014 B2
8708961 Field et al. Apr 2014 B2
8751237 Kubota Jun 2014 B2
8753326 Chong et al. Jun 2014 B2
8753331 Murphy Jun 2014 B2
8764707 Moberg et al. Jul 2014 B2
8764723 Chong et al. Jul 2014 B2
8771222 Kanderian et al. Jul 2014 B2
8777896 Starkweather et al. Jul 2014 B2
8777924 Kanderian et al. Jul 2014 B2
8777925 Patton Jul 2014 B2
8784369 Starkweather et al. Jul 2014 B2
8784370 Lebel et al. Jul 2014 B2
8790295 Sigg et al. Jul 2014 B1
8795224 Starkweather et al. Aug 2014 B2
8795231 Chong et al. Aug 2014 B2
8795260 Drew Aug 2014 B2
8801668 Ali et al. Aug 2014 B2
8801679 Iio et al. Aug 2014 B2
8810394 Kalpin Aug 2014 B2
8814379 Griffiths et al. Aug 2014 B2
8915882 Cabiri Dec 2014 B2
8920374 Bokelman et al. Dec 2014 B2
D723157 Clemente et al. Feb 2015 S
9061104 Daniel Jun 2015 B2
9061110 Avery et al. Jun 2015 B2
9072827 Cabiri Jul 2015 B2
9089475 Fangrow Jul 2015 B2
9089641 Kavazov Jul 2015 B2
9149575 Cabiri Oct 2015 B2
9393365 Cabiri Jul 2016 B2
D768288 O'Connor et al. Oct 2016 S
9463280 Cabiri Oct 2016 B2
9492610 Cabiri Nov 2016 B2
D774640 Tyce et al. Dec 2016 S
9511190 Cabiri Dec 2016 B2
9522234 Cabiri Dec 2016 B2
D776262 Tyce et al. Jan 2017 S
D776263 Tyce et al. Jan 2017 S
D776264 Tyce et al. Jan 2017 S
D776265 Tyce et al. Jan 2017 S
9572926 Cabiri Feb 2017 B2
9707335 Agard et al. Jul 2017 B2
D794776 Tyce et al. Aug 2017 S
9737655 Clemente et al. Aug 2017 B2
9782545 Gross et al. Oct 2017 B2
9802030 Clemente et al. Oct 2017 B2
D804019 Costello et al. Nov 2017 S
9814832 Agard et al. Nov 2017 B2
D804650 Costello et al. Dec 2017 S
D805186 Costello et al. Dec 2017 S
D805187 Costello et al. Dec 2017 S
D805188 Costello et al. Dec 2017 S
D805189 Costello et al. Dec 2017 S
D805190 Costello et al. Dec 2017 S
9861759 Gross et al. Jan 2018 B2
D810278 Cabiri et al. Feb 2018 S
D810279 Cabiri et al. Feb 2018 S
D811583 Cabiri et al. Feb 2018 S
D811584 Cabiri et al. Feb 2018 S
D817481 Cabiri et al. May 2018 S
D851752 Nazzaro et al. Jun 2019 S
D865945 Nazzaro et al. Nov 2019 S
20010025168 Gross et al. Sep 2001 A1
20010041869 Causey et al. Nov 2001 A1
20020010423 Gross et al. Jan 2002 A1
20020029018 Jeffrey Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020043951 Moberg Apr 2002 A1
20020055711 Lavi et al. May 2002 A1
20020065488 Suzuki et al. May 2002 A1
20020100472 Casper Aug 2002 A1
20020107487 Preuthun Aug 2002 A1
20020123740 Flaherty et al. Sep 2002 A1
20020161332 Ramey Oct 2002 A1
20020169215 Meng Nov 2002 A1
20030009133 Ramey Jan 2003 A1
20030109827 Lavi et al. Jun 2003 A1
20030125671 Aramata et al. Jul 2003 A1
20030135159 Daily et al. Jul 2003 A1
20030160683 Blomquist Aug 2003 A1
20030171717 Farrugia et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030199825 Flaherty Oct 2003 A1
20030199827 Thorne Oct 2003 A1
20030236498 Gross et al. Dec 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040015131 Flaherty et al. Jan 2004 A1
20040064088 Gorman et al. Apr 2004 A1
20040085215 Moberg et al. May 2004 A1
20040092873 Moberg May 2004 A1
20040116866 Gorman et al. Jun 2004 A1
20040127857 Shemesh et al. Jul 2004 A1
20040158172 Hancock Aug 2004 A1
20040186419 Cho Sep 2004 A1
20040186424 Hjertman Sep 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20050033234 Sadowski et al. Feb 2005 A1
20050049553 Triplett et al. Mar 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050070845 Faries et al. Mar 2005 A1
20050071487 Lu et al. Mar 2005 A1
20050113761 Faust et al. May 2005 A1
20050159706 Wilkinson et al. Jul 2005 A1
20050171476 Judson et al. Aug 2005 A1
20050171512 Flaherty Aug 2005 A1
20050177136 Miller Aug 2005 A1
20050197650 Sugimoto et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050238507 Diianni et al. Oct 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060013716 Nason et al. Jan 2006 A1
20060030816 Zubry Feb 2006 A1
20060095014 Ethelfeld May 2006 A1
20060122577 Poulsen et al. Jun 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173408 Wyrick Aug 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173439 Thorne et al. Aug 2006 A1
20060184154 Moberg et al. Aug 2006 A1
20060195029 Shults et al. Aug 2006 A1
20060211982 Prestrelski et al. Sep 2006 A1
20060229569 Lavi et al. Oct 2006 A1
20060264831 Skwarek et al. Nov 2006 A1
20060264889 Moberg et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20060264894 Moberg et al. Nov 2006 A1
20060270987 Peter Nov 2006 A1
20060283465 Nickel et al. Dec 2006 A1
20060293722 Slatkine et al. Dec 2006 A1
20070016381 Kamath et al. Jan 2007 A1
20070021733 Hansen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070073228 Mernoe et al. Mar 2007 A1
20070106218 Yodfat et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070123819 Mernoe et al. May 2007 A1
20070129688 Scheurer et al. Jun 2007 A1
20070149926 Moberg et al. Jun 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070185449 Mernoe Aug 2007 A1
20070191770 Moberg et al. Aug 2007 A1
20070197968 Pongpairochana et al. Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070219480 Kamen et al. Sep 2007 A1
20070233038 Pruitt et al. Oct 2007 A1
20070282269 Carter et al. Dec 2007 A1
20080021439 Brittingham et al. Jan 2008 A1
20080033367 Haury et al. Feb 2008 A1
20080033369 Kohlbrenner et al. Feb 2008 A1
20080033393 Edwards et al. Feb 2008 A1
20080051710 Moberg et al. Feb 2008 A1
20080051711 Mounce et al. Feb 2008 A1
20080051727 Moberg et al. Feb 2008 A1
20080051730 Bikovsky Feb 2008 A1
20080059133 Edwards et al. Mar 2008 A1
20080097381 Moberg et al. Apr 2008 A1
20080099015 Pocock May 2008 A1
20080108951 Jerde et al. May 2008 A1
20080125700 Moberg et al. May 2008 A1
20080140006 Eskuri et al. Jun 2008 A1
20080140018 Enggaard et al. Jun 2008 A1
20080147004 Mann et al. Jun 2008 A1
20080156476 Smisson et al. Jul 2008 A1
20080167641 Hansen et al. Jul 2008 A1
20080188813 Miller et al. Aug 2008 A1
20080195049 Thalmann et al. Aug 2008 A1
20080208138 Lim et al. Aug 2008 A1
20080215006 Thorkild Sep 2008 A1
20080215015 Cindrich et al. Sep 2008 A1
20080221522 Moberg et al. Sep 2008 A1
20080221523 Moberg et al. Sep 2008 A1
20080234627 Dent et al. Sep 2008 A1
20080243087 Enggaard et al. Oct 2008 A1
20080249473 Rutti et al. Oct 2008 A1
20080255516 Yodfat et al. Oct 2008 A1
20080262436 Olson Oct 2008 A1
20080269687 Chong et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080274630 Shelton et al. Nov 2008 A1
20080275407 Scheurer Nov 2008 A1
20080281270 Cross et al. Nov 2008 A1
20080294143 Tanaka et al. Nov 2008 A1
20080306449 Kristensen et al. Dec 2008 A1
20080312601 Cane Dec 2008 A1
20080319416 Yodat et al. Dec 2008 A1
20090041805 Walker Feb 2009 A1
20090043253 Podaima Feb 2009 A1
20090048347 Cohen et al. Feb 2009 A1
20090054750 Jennewine Feb 2009 A1
20090054852 Takano et al. Feb 2009 A1
20090062767 Van et al. Mar 2009 A1
20090069784 Estes et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076453 Mejlhede et al. Mar 2009 A1
20090088694 Carter et al. Apr 2009 A1
20090088731 Campbell et al. Apr 2009 A1
20090093792 Gross et al. Apr 2009 A1
20090093793 Gross et al. Apr 2009 A1
20090105650 Wiegel et al. Apr 2009 A1
20090124977 Jensen May 2009 A1
20090131860 Nielsen May 2009 A1
20090139724 Gray et al. Jun 2009 A1
20090143730 De et al. Jun 2009 A1
20090143735 De Polo et al. Jun 2009 A1
20090149830 Spector Jun 2009 A1
20090182277 Carter Jul 2009 A1
20090204076 Liversidge Aug 2009 A1
20090209896 Selevan Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090234319 Marksteiner Sep 2009 A1
20090240240 Hines et al. Sep 2009 A1
20090243234 Sharif Oct 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259176 Yairi Oct 2009 A1
20090281585 Katzman et al. Nov 2009 A1
20090299290 Moberg Dec 2009 A1
20090299397 Ruan et al. Dec 2009 A1
20090326459 Shipway et al. Dec 2009 A1
20090326509 Muse et al. Dec 2009 A1
20100030156 Beebe et al. Feb 2010 A1
20100030198 Beebe et al. Feb 2010 A1
20100037680 Moberg et al. Feb 2010 A1
20100044270 Noble Feb 2010 A1
20100049128 Mckenzie et al. Feb 2010 A1
20100049144 Mcconnell et al. Feb 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100076412 Rush et al. Mar 2010 A1
20100081993 O'Connor Apr 2010 A1
20100094255 Nycz et al. Apr 2010 A1
20100100076 Rush et al. Apr 2010 A1
20100100077 Rush et al. Apr 2010 A1
20100106098 Atterbury et al. Apr 2010 A1
20100121314 Iobbi May 2010 A1
20100137790 Yodfat Jun 2010 A1
20100137831 Tsais Jun 2010 A1
20100145303 Yodfat et al. Jun 2010 A1
20100145305 Alon Jun 2010 A1
20100152658 Hanson et al. Jun 2010 A1
20100162548 Leidig Jul 2010 A1
20100168607 Miesel Jul 2010 A1
20100168683 Cabiri Jul 2010 A1
20100198157 Gyrn et al. Aug 2010 A1
20100204657 Yodfat et al. Aug 2010 A1
20100211011 Haar Aug 2010 A1
20100217192 Moberg et al. Aug 2010 A1
20100217193 Moberg et al. Aug 2010 A1
20100234767 Sarstedt Sep 2010 A1
20100234805 Kaufmann et al. Sep 2010 A1
20100234830 Straessler et al. Sep 2010 A1
20100241065 Moberg et al. Sep 2010 A1
20100264931 Lindegger et al. Oct 2010 A1
20100274112 Hoss et al. Oct 2010 A1
20100274192 Mernoe Oct 2010 A1
20100274202 Hyde et al. Oct 2010 A1
20100276411 Hansen et al. Nov 2010 A1
20100280499 Yodfat et al. Nov 2010 A1
20100331826 Field et al. Dec 2010 A1
20110034900 Yodfat et al. Feb 2011 A1
20110054399 Chong et al. Mar 2011 A1
20110054400 Chong et al. Mar 2011 A1
20110060284 Harr Mar 2011 A1
20110066131 Cabiri Mar 2011 A1
20110119033 Moberg et al. May 2011 A1
20110125056 Merchant May 2011 A1
20110137239 DeBelser et al. Jun 2011 A1
20110144584 Wozencroft Jun 2011 A1
20110160654 Hanson et al. Jun 2011 A1
20110160655 Hanson et al. Jun 2011 A1
20110160666 Hanson et al. Jun 2011 A1
20110160669 Gyrn et al. Jun 2011 A1
20110172645 Moga et al. Jul 2011 A1
20110172745 Na et al. Jul 2011 A1
20110178463 Cabiri Jul 2011 A1
20110178472 Cabiri Jul 2011 A1
20110184342 Pesach et al. Jul 2011 A1
20110201998 Pongpairochana et al. Aug 2011 A1
20110224614 Moberg et al. Sep 2011 A1
20110238031 Mair et al. Sep 2011 A1
20110245773 Estes et al. Oct 2011 A1
20110264383 Moberg et al. Oct 2011 A1
20110270160 Mernoe Nov 2011 A1
20110282282 Lorenzen et al. Nov 2011 A1
20110282296 Harms et al. Nov 2011 A1
20110295205 Kaufmann et al. Dec 2011 A1
20110313238 Reichenbach et al. Dec 2011 A1
20110313351 Kamen et al. Dec 2011 A1
20110319861 Wilk Dec 2011 A1
20110319919 Curry et al. Dec 2011 A1
20120004602 Hanson et al. Jan 2012 A1
20120010594 Holt et al. Jan 2012 A1
20120022344 Kube Jan 2012 A1
20120022499 Anderson et al. Jan 2012 A1
20120025995 Moberg et al. Feb 2012 A1
20120029431 Hwang et al. Feb 2012 A1
20120035546 Cabiri Feb 2012 A1
20120041364 Smith Feb 2012 A1
20120041370 Moberg et al. Feb 2012 A1
20120041414 Estes et al. Feb 2012 A1
20120059332 Woehr et al. Mar 2012 A1
20120071819 Brueggemann et al. Mar 2012 A1
20120071828 Tojo et al. Mar 2012 A1
20120096953 Bente et al. Apr 2012 A1
20120096954 Vazquez et al. Apr 2012 A1
20120101436 Bazargan et al. Apr 2012 A1
20120108933 Liang et al. May 2012 A1
20120129362 Hampo et al. May 2012 A1
20120132203 Hodson May 2012 A1
20120160033 Kow et al. Jun 2012 A1
20120165733 Bazargan et al. Jun 2012 A1
20120165780 Bazargan et al. Jun 2012 A1
20120215169 Moberg et al. Aug 2012 A1
20120215199 Moberg et al. Aug 2012 A1
20120226234 Bazargan et al. Sep 2012 A1
20120259282 Alderete et al. Oct 2012 A1
20120310153 Moberg et al. Dec 2012 A1
20130012875 Gross et al. Jan 2013 A1
20130060233 O'Connor et al. Mar 2013 A1
20130068319 Plumptre et al. Mar 2013 A1
20130085457 Schiff et al. Apr 2013 A1
20130089992 Yang Apr 2013 A1
20130096509 Avery et al. Apr 2013 A1
20130110049 Cronenberg et al. May 2013 A1
20130133438 Kow et al. May 2013 A1
20130175192 Iio et al. Jul 2013 A1
20130218089 Davies et al. Aug 2013 A1
20130218092 Davies et al. Aug 2013 A1
20130237953 Kow et al. Sep 2013 A1
20130245595 Kow et al. Sep 2013 A1
20130245596 Cabiri et al. Sep 2013 A1
20130253419 Favreau Sep 2013 A1
20130253420 Favreau Sep 2013 A1
20130253421 Favreau Sep 2013 A1
20130253472 Cabiri Sep 2013 A1
20130296792 Cabiri Nov 2013 A1
20130296799 Degtiar et al. Nov 2013 A1
20130304021 Cabiri et al. Nov 2013 A1
20130310753 Cabiri Nov 2013 A1
20130323699 Edwards et al. Dec 2013 A1
20130331791 Gross et al. Dec 2013 A1
20140012229 Bokelman Jan 2014 A1
20140055073 Favreau Feb 2014 A1
20140055076 Favreau Feb 2014 A1
20140058349 Bazargan et al. Feb 2014 A1
20140083517 Moia et al. Mar 2014 A1
20140094755 Bazargan et al. Apr 2014 A1
20140128807 Moberg et al. May 2014 A1
20140128815 Cabiri et al. May 2014 A1
20140128835 Moberg et al. May 2014 A1
20140135692 Alderete et al. May 2014 A1
20140135694 Moberg et al. May 2014 A1
20140142499 Moberg et al. May 2014 A1
20140148784 Anderson et al. May 2014 A1
20140148785 Moberg et al. May 2014 A1
20140163522 Alderete et al. Jun 2014 A1
20140171881 Cabiri Jun 2014 A1
20140188073 Cabiri et al. Jul 2014 A1
20140194819 Maule et al. Jul 2014 A1
20140194854 Tsais Jul 2014 A1
20140207064 Yavorsky Jul 2014 A1
20140207065 Yavorsky Jul 2014 A1
20140207066 Yavorsky Jul 2014 A1
20140210631 Zavis Jul 2014 A1
20140213975 Clemente et al. Jul 2014 A1
20140236087 Alderete et al. Aug 2014 A1
20140261758 Wlodarczyk et al. Sep 2014 A1
20140288511 Tan-Malecki et al. Sep 2014 A1
20140330240 Cabiri et al. Nov 2014 A1
20150011965 Cabiri Jan 2015 A1
20150011976 Vouillamoz et al. Jan 2015 A1
20150032084 Cabiri Jan 2015 A1
20150057613 Clemente et al. Feb 2015 A1
20150119797 Cabiri Apr 2015 A1
20150174346 Dhuppad Jun 2015 A1
20150224253 Cabiri Aug 2015 A1
20150297833 Henderson Oct 2015 A1
20150367074 Draper Dec 2015 A1
20160015910 Mukai et al. Jan 2016 A1
20160058941 Wu et al. Mar 2016 A1
20160199592 Eggert et al. Jul 2016 A1
20160228644 Cabiri Aug 2016 A1
20160256352 Bar-El et al. Sep 2016 A1
20170028132 Cronenberg et al. Feb 2017 A1
20170106138 Cabiri Apr 2017 A1
20170224915 Destefano et al. Aug 2017 A1
20170281859 Agard et al. Oct 2017 A1
20170312450 Gross et al. Nov 2017 A1
20170354781 Cronenberg et al. Dec 2017 A1
20170354782 Quinn et al. Dec 2017 A1
20170354783 Gazeley et al. Dec 2017 A1
20170354785 Gazeley et al. Dec 2017 A1
20170354788 Quinn et al. Dec 2017 A1
20180001073 Clemente et al. Jan 2018 A1
20180008769 O'Connor et al. Jan 2018 A1
20180021508 Destefano et al. Jan 2018 A1
20180028747 Hanson et al. Feb 2018 A1
20180043091 Agard et al. Feb 2018 A1
20180055995 Hanson et al. Mar 2018 A1
20180221584 Grimoldby Aug 2018 A1
20180236173 Mccaffrey et al. Aug 2018 A1
20190091404 Nazzaro et al. Mar 2019 A1
20190117880 Hirschel et al. Apr 2019 A1
20190366012 Gross et al. Dec 2019 A1
20200282144 Pearson Sep 2020 A1
Foreign Referenced Citations (122)
Number Date Country
1224341 Jul 1999 CN
1408443 Apr 2003 CN
1636605 Jul 2005 CN
1747683 Mar 2006 CN
1863566 Nov 2006 CN
1929884 Mar 2007 CN
101001661 Jul 2007 CN
101090749 Dec 2007 CN
101239205 Aug 2008 CN
101460207 Jun 2009 CN
101687083 Mar 2010 CN
101868273 Oct 2010 CN
101970033 Feb 2011 CN
201941304 Aug 2011 CN
102186733 Sep 2011 CN
102256657 Nov 2011 CN
102639169 Aug 2012 CN
104703641 Jun 2015 CN
104955504 Sep 2015 CN
1064693 Sep 1959 DE
0017412 Oct 1980 EP
0222656 May 1987 EP
0401179 Dec 1990 EP
0744975 Dec 1996 EP
1530979 May 2005 EP
1666080 Jun 2006 EP
2060606 May 2009 EP
2345441 Jul 2011 EP
2498589 Sep 2012 EP
2698180 Feb 2014 EP
2727617 May 2014 EP
2454483 Aug 2015 EP
07-194701 Aug 1995 JP
09-505758 Jun 1997 JP
1224341 Jul 1999 JP
2001-512992 Aug 2001 JP
2002-505601 Feb 2002 JP
2002-507459 Mar 2002 JP
2002-528676 Sep 2002 JP
2003-501157 Jan 2003 JP
2003-534061 Nov 2003 JP
2004-501721 Jan 2004 JP
2004-512100 Apr 2004 JP
2003-527138 Aug 2005 JP
2005-523127 Aug 2005 JP
2005-270629 Oct 2005 JP
2007-509661 Apr 2007 JP
2008100762 May 2008 JP
2008-534131 Aug 2008 JP
2008-220961 Sep 2008 JP
2009-502273 Jan 2009 JP
2015524722 Aug 2015 JP
2015536715 Dec 2015 JP
8911302 Nov 1989 WO
9009202 Aug 1990 WO
9307922 Apr 1993 WO
9407553 Apr 1994 WO
9513838 May 1995 WO
9521645 Aug 1995 WO
9609083 Mar 1996 WO
9632975 Oct 1996 WO
9700091 Jan 1997 WO
9710012 Mar 1997 WO
9721457 Jun 1997 WO
9733638 Sep 1997 WO
9857683 Dec 1998 WO
9929151 Jun 1999 WO
9959665 Nov 1999 WO
0025844 May 2000 WO
0187384 Nov 2001 WO
0189607 Nov 2001 WO
0189613 Nov 2001 WO
0202165 Jan 2002 WO
0234315 May 2002 WO
0272182 Sep 2002 WO
0390833 Nov 2003 WO
2004032990 Apr 2004 WO
2004105841 Dec 2004 WO
2005018703 Mar 2005 WO
2005037350 Apr 2005 WO
2006037434 Apr 2006 WO
2006069380 Jun 2006 WO
2006102676 Sep 2006 WO
2006104806 Oct 2006 WO
2007051563 May 2007 WO
2007056504 May 2007 WO
2007092618 Aug 2007 WO
2007130868 Nov 2007 WO
2008001377 Jan 2008 WO
2008014908 Feb 2008 WO
2008024810 Feb 2008 WO
2008024814 Feb 2008 WO
2008057976 May 2008 WO
2008072229 Jun 2008 WO
2008076459 Jun 2008 WO
2008078318 Jul 2008 WO
2008129549 Oct 2008 WO
2009046989 Apr 2009 WO
2009044401 Apr 2009 WO
2009081262 Jul 2009 WO
2009125398 Oct 2009 WO
2009144085 Dec 2009 WO
2010078227 Jul 2010 WO
2010078242 Jul 2010 WO
2011034799 Mar 2011 WO
2011075105 Jun 2011 WO
2011090955 Jul 2011 WO
2011090956 Jul 2011 WO
2011113806 Sep 2011 WO
2011156373 Dec 2011 WO
2012040528 Mar 2012 WO
2012032411 Mar 2012 WO
2012160157 Nov 2012 WO
2012160160 Nov 2012 WO
2013115843 Aug 2013 WO
2013148270 Oct 2013 WO
2013148435 Oct 2013 WO
2013173092 Nov 2013 WO
2014070453 May 2014 WO
2014107408 Jul 2014 WO
2014179210 Nov 2014 WO
2014179774 Nov 2014 WO
Non-Patent Literature Citations (161)
Entry
Office Action dated Oct. 11, 2017 in U.S. Appl. No. 29/605,061, by Cabiri.
Office Action dated Oct. 28, 2011 in U.S. Appl. No. 12/615,828.
Office Action dated Oct. 28, 2015 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated Oct. 5, 2017 in U.S. Appl. No. 29/605,068, by Cabiri.
Office Action dated Oct. 6, 2017 in U.S. Appl. No. 29/604,616, by Cabiri.
Office Action dated Oct. 6, 2017 in U.S. Appl. No. 29/605,051, by Cabiri.
Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/873,335.
Office Action dated Sep. 13, 2017 in EP Application No. 13783458.6.
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri.
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550068.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069.
Office Action dated Sep. 29, 2013 in CN Application No. 201080040968.7.
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250, by Cabiri.
Office Action dated Sep. 30, 2015 in U.S. Appl. No. 13/667,739 by Cabiri.
Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/345,818.
Office Action dated Sep. 9, 2015 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Feb. 19, 2016 in U.S. Appl. No. 14/553,399 by Cabiri.
Office Action dated Feb. 3, 2016 in U.S. Appl. No. 14/931,439 by Cabiri.
Office Action dated Jul. 1, 2016 in U.S. Appl. No. 15/132,740 by Cabiri.
Office Action dated Jul. 8, 2016 in CN Application No. 201510695320.8.
Office Action dated May 4, 2016 in U.S. Appl. No. 15/069,080 by Cabiri.
Office Action dated Nov. 6, 2015 in U.S. Appl. No. 14/715,791 by Cabiri.
U.S. Appl. No. 12/559,563, filed Sep. 15, 2009.
U.S. Appl. No. 12/689,249, filed Jan. 19, 2010.
U.S. Appl. No. 12/689,250, filed Jan. 19, 2010.
U.S. Appl. No. 13/429,840 by Cabiri, filed Mar. 26, 2012.
U.S. Appl. No. 13/429,942 by Cabiri, filed Mar. 26, 2012.
U.S. Appl. No. 13/472,112 by Cabiri, filed May 15, 2012.
U.S. Appl. No. 13/521,167 by Cabiri, filed Jul. 9, 2012.
U.S. Appl. No. 13/521,181 by Cabiri, filed Jul. 9, 2012.
U.S. Appl. No. 13/643,470 by Alon, filed Oct. 25, 2012.
U.S. Appl. No. 13/733,516 by Cabiri, filed Jan. 3, 2013.
U.S. Appl. No. 13/873,335 by Filman, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,017 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,085 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,121 by Degtiar, filed Apr. 30, 2013.
U.S. Appl. No. 13/886,867 by Cabiri, filed May 3, 2013.
U.S. Appl. No. 13/892,905 by Cabiri, filed May 13, 2013.
U.S. Appl. No. 13/964,651 by Gross, filed Aug. 12, 2013.
U.S. Appl. No. 14/193,692 by Gross, filed Feb. 28, 2014.
U.S. Appl. No. 14/258,661 by Cabiri, filed Apr. 22, 2014.
U.S. Appl. No. 14/372,384 by Cabiri, filed Jul. 15, 2014.
U.S. Appl. No. 14/553,399 by Cabiri, filed Nov. 25, 2014.
U.S. Appl. No. 14/593,041 by Cabiri, filed Jan. 9, 2015.
U.S. Appl. No. 14/593,051 by Gross, filed Jan. 9, 2015.
U.S. Appl. No. 14/638,525 by Filman, filed Mar. 4, 2015.
U.S. Appl. No. 14/683,193 by Cabiri, filed Apr. 10, 2015.
U.S. Appl. No. 14/715,791 by Cabiri, filed May 19, 2015.
U.S. Appl. No. 14/725,009 by Bar-El, filed May 29, 2015.
Office Action dated Jul. 9, 2020 in European Application No. 16828833.0.
Office Action dated Sep. 29, 2019 in JP Application No. 2019-505206.
Office Action dated Sep. 27, 2020 in Chinese Application No. 201680088261.0.
Copaxone(Registered), Innovative Drugs, Teva Pharmaceuticals, downloaded from webpage http://levapharm.com/copaxone/, Download date: Jan. 2009, original posting date: unknown, 3 pages.
Daikyo Crystal Zenith(Registered) polymer, Manufactured by Daikyo Seiko, Lid. (Jun. 25, 2008).
English translation of an Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X.
English translation of an Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X.
Extended European Search Report dated Aug. 7, 2014 in EP Application No. 1417477.4.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8.
Extended European Search Report dated Mar. 27, 2014 in EP Application No. 14154717.4.
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US 13/31598.
Int'l Preliminary Report on Patentability dated Nov. 12, 2015 in Int'l Application No. PCT/US14/35662.
Int'l Search Report and Written Opinion dated Jan. 12, 2011 in Int'l Application No. PCT/US2010/048556; Written Opinion.
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312.
Int'l Preliminary Report on Patentability dated Aug. 14, 2014 in Int'l Application No. PCT/US2012/050696.
Int'l Preliminary Report on Patentability dated Aug. 2, 2012 in Int'l Application No. PCT/US2011/021604.
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US11/21605.
Int'l Preliminary Report on Patentability dated Jul. 16, 2015 in Int'l Application No. PCT/US2013/078040.
Int'l Preliminary Report on Patentability dated May 14, 2015 in Int'l Application No. PCT/US2013/065211.
Int'l Preliminary Report on Patentability dated Nov. 27, 2014 in Int'l Application No. PCT/US2013/039465.
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US2013/033118.
Int'l Preliminary Report on Patentability dated Sep. 1, 2011 in Int'l Application No. PCT/US2010/048556.
Int'l Search Report and Written Opinion dated Apr. 3, 2014 in Int'l Application No. PCT/US2013/078040.
Int'l Search Report and Written Opinion dated Apr. 5, 2013 in Int'l Application No. PCT/US2012/050696.
Int'l Search Report and Written Opinion dated Aug. 28, 2014 in Int'l Application No. PCT/US2014/035662.
Int'l Search Report and Written Opinion dated Aug. 5, 2013 in Int'l Application No. PCT/US2013/033118.
Int'l Search Report and Written Opinion dated Jan. 7, 2014 in Int'l Application No. PCT/US2013/065211.
Int'l Search Report and Written Opinion dated Jul. 26, 2013 in Int'l Application No. PCT/US2012/039465.
Int'l Search Report and Written Opinion dated Jul. 31, 2014 in Int'l Application No. PCT/US2014/033598.
Int'l Search Report and Written Opinion dated Jun. 30, 2014 in Int'l Application No. PCT/US2013/031598.
Int'l Search Report and Written Opinion dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312.
Int'l Search Report dated Apr. 26, 2010 in Int'l Application No. PCT/US2009/069552.
Int'l Search Report dated Jun. 17, 2011 in Int'l Application No. PCT/US2011/021604.
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US11/21605.
Int'l Search Report dated Sep. 22, 2011 in Int'l Application No. PCT/IL11/00368; Written Opinion.
International Preliminary Report on Patentability and Written Opinion dated Jul. 5, 2011 in International Application No. PCT/US2009/069552.
Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 29/479,307 by Norton.
Notice of Allowance dated Apr. 25, 2016 in U.S. Appl. No. 14/553,399 by Cabiri.
Notice of Allowance dated May 11, 2016 in U.S. Appl. No. 14/931,439 by Cabiri.
Offce Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Apr. 19, 2016 in U.S. Appl. No. 14/372,384 by Cabiri.
Office Action dated Apr. 24, 2013 in CN Application No. 201080040968.7.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Office Action dated Aug. 13, 2015 in U.S. Appl. No. 14/553,399 by Cabiri.
Office Action dated Aug. 13, 2018 in IN Application No. 857/KOLNP/2012.
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X.
Office Action dated Aug. 15, 2013 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated Aug. 26, 2014 in CN Application No. 201180006567.4.
Office Action dated Aug. 6, 2014 in EP Appl. No. 11 707 942.6.
Office Action dated Dec. 10, 2013 in CN Application No. 201180006567.4.
Office Action dated Dec. 17, 2013 in JP Application No. 2012-529808.
Int'l Search Report and Written Opinion dated Apr. 26, 2017 in Int'l Application No. PCT/US2016/068049.
Office Action dated Dec. 29, 2016 in CN Application No. 2015106953208.
Office Action dated Dec. 3, 2015 in CN Application No. 201280068544.0.
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Office Action dated Feb. 21, 2012 in U.S. Appl. No. 12/689,249.
Office Action dated Feb. 24, 2015 in U.S. Appl. No. 14/258,661 by Cabiri.
Office Action dated Feb. 24, 2016 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0.
Office Action dated Feb. 4, 2014 in EP Application No. 11 707 942.6.
Office Action dated Jan. 15, 2016 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Jan. 16, 2014 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated Jan. 28, 2015 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated Jan. 4, 2016 in U.S. Appl. No. 13/892,905 by Cabiri.
Office Action dated Jan. 5, 2016 in U.S. Appl. No. 14/696,644 by Cabiri.
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595.
Office Action dated Jan. 8, 2014 in U.S. Appl. No. 13/521,167 by Cabiri.
Office Action dated Jul. 13, 2011 in U.S. Appl. No. 12/559,563 by Cabiri.
Office Action dated Jul. 2, 2012 in U.S. Appl. No. 13/272,555 by Cabiri.
Office Action dated Jul. 29, 2013 in JP Application No. 2012-529808.
Office Action dated Jul. 29, 2016 in U.S. Appl. No. 14/696,644, by Cabiri.
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Jul. 7, 2016 in U.S. Appl. No. 13/892,905 by Cabiri.
Office Action dated Jun. 1, 2016 in CN Application No. 2013800274556.
Office Action dated Jun. 17, 2016 in CN Application No. 201280068544.0.
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595.
Office Action dated Jun. 4, 2015 in U.S. Appl. No. 13/667,739 by Cabiri.
Office Action dated Mar. 10, 2015 in CN Application No. 201180006567.4.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Mar. 15, 2018 in U.S. Appl. No. 29/628,592 by Cabiri.
Office Action dated Mar. 31, 2015 in JP Application No. 2012-550068.
Office Action dated May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman.
Office Action dated May 13, 2015 in CN Application No. 201380025566.3.
Office Action dated May 16, 2012 in U.S. Appl. No. 12/615,828.
Office Action dated May 17, 2016 in U.S. Appl. No. 13/886,867 by Cabiri.
Office Action dated May 18, 2015 in U.S. Appl. No. 13/429,942 by Cabiri.
Office Action dated May 18, 2016 in U.S. Appl. No. 13/667,739 by Cabiri.
Office Action dated May 23, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated May 24, 2017 in CN Application No. 2013800571961.
Office Action dated May 3, 2012 in CN Application No. 200880117084.X.
Office Action dated May 7, 2015 in JP Application No. 2012-550069.
Office Action dated Nov. 16, 2015 in U.S. Appl. No. 13/733,516 by Cabiri.
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0.
Office Action dated Nov. 2, 2016 in CN Application No. 2013800571961.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/429,840 by Cabiri.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/372,384 by Cabiri.
Office Action dated Nov. 4, 2013 in EP Application No. 11 709 234.6.
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595.
Office Action dated Nov. 5, 2014 in U.S. Appl. No. 13/643,470 by Alon.
U.S. Appl. No. 14/850,450 by Gross, filed Sep. 10, 2015.
U.S. Appl. No. 14/861,478 by Cabiri, filed Sep. 22, 2015.
U.S. Appl. No. 14/880,673 by Cabiri, filed Oct. 12, 2015.
U.S. Appl. No. 14/931,439 by Cabiri, filed Nov. 3, 2015.
U.S. Appl. No. 15/196,775 by Cabiri, filed Jun. 29, 2016.
U.S. Appl. No. 29/479,307 by Norton, filed Jan. 14, 2014.
U.S. Appl. No. 60/997,459, filed Oct. 2, 2007.
Related Publications (1)
Number Date Country
20190151562 A1 May 2019 US
Provisional Applications (1)
Number Date Country
62369505 Aug 2016 US